Expedited Approval

Stakeholders Recommend Manufacturers Share Off-Label Information on Medications Awaiting FDA Approval with Decision Makers

Press Release: Biopharmaceutical companies and health care decision makers would be able to more easily communicate information on products awaiting Food and Drug Administration (FDA) approval, under recommendations developed at an Academy of Managed Care Pharmacy (AMCP) partnership forum this week.
Expedited Approval, Formulary & Utilization Management